Disulfide With Humanized Monoclonal BI 655130 Kappa-chain Uses, Dosage, Side Effects and more
Disulfide With Humanized Monoclonal BI 655130 Kappa-chain is under investigation in clinical trial NCT03886246 (A 5-year Study to Test BI 655130 in Patients With Generalized Pustular Psoriasis Who Took Part in Previous Studies With BI 655130).
| Trade Name | Disulfide With Humanized Monoclonal BI 655130 Kappa-chain |
| Generic | Spesolimab |
| Spesolimab Other Names | Immunoglobulin G1, anti-(human interleukin 36 receptor) (humanized monoclonal BI 655130 gamma1-chain), disulfide with humanized monoclonal BI 655130 kappa-chain, dimer, Spesolimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
